Metastatic renal cell cancer: Major response to oxaliplatin, 5-fluorouracil, L-folinic acid (FOL-FOX) combination

被引：0
作者：
Chauffert, B [1 ]
Bonnotte, B [1 ]
Chvetzoff, G [1 ]
Flesch, M [1 ]
机构：
[1] CHU Dijon, Serv Med Interne Immunol Clin & Oncol, F-21034 Dijon, France
来源：
PRESSE MEDICALE | 1998年 / 27卷 / 18期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：859 / 859
页数：1
相关论文
共 50 条
[21]   5-FLUOROURACIL AND FOLINIC ACID IN THE TREATMENT OF METASTATIC COLORECTAL-CANCER - REPLY [J].
BUDD, GT ;
BUKOWSKI, RM ;
MCCRACKEN, JD ;
MACDONALD, JS .
JOURNAL OF CLINICAL ONCOLOGY, 1987, 5 (09) :1492-1493
[22]   Sequential chemotherapy with dose-dense docetaxel, cisplatin, folinic acid and 5-fluorouracil (TCF-dd) followed by combination of oxaliplatin, folinic acid, 5-fluorouracil and irinotecan (COFFI) in metastatic gastric cancer: results of a phase II trial [J].
Matteo Dalla Chiesa ;
Gianluca Tomasello ;
Sebastiano Buti ;
Rodrigo Kraft Rovere ;
Matteo Brighenti ;
Silvia Lazzarelli ;
Gianvito Donati ;
Rodolfo Passalacqua .
Cancer Chemotherapy and Pharmacology, 2011, 67 :41-48
[23]   Sequential chemotherapy with dose-dense docetaxel, cisplatin, folinic acid and 5-fluorouracil (TCF-dd) followed by combination of oxaliplatin, folinic acid, 5-fluorouracil and irinotecan (COFFI) in metastatic gastric cancer: results of a phase II trial [J].
Dalla Chiesa, Matteo ;
Tomasello, Gianluca ;
Buti, Sebastiano ;
Rovere, Rodrigo Kraft ;
Brighenti, Matteo ;
Lazzarelli, Silvia ;
Donati, Gianvito ;
Passalacqua, Rodolfo .
CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2011, 67 (01) :41-48
[24]   Hepatic artery infusion using oxaliplatin in combination with 5-fluorouracil, folinic acid and mitomycin C: Oxaliplatin pharmacokinetics and feasibility [J].
Guthoff, I ;
Lotspeich, E ;
Fester, C ;
Wallin, I ;
Schatz, M ;
Ehrsson, H ;
Kornmann, M .
ANTICANCER RESEARCH, 2003, 23 (6D) :5203-5208
[25]   The combination of 5-fluorouracil and folinic acid in the treatment of breast cancer: The emerging role [J].
Zaniboni, A .
CANCER JOURNAL - FRANCE, 1996, 9 (02) :77-78
[26]   Gemcitabine in combination with 5-fluorouracil with or without folinic acid in the treatment of pancreatic cancer [J].
Oettle, H ;
Riess, H .
CANCER, 2002, 95 (04) :912-922
[27]   CLINICAL OUTCOME OF PATIENTS TREATED WITH HEPATIC ARTERIAL INFUSION OF OXALIPLATIN AND L-FOLINIC ACID MODULATED 5-FLUOROURACIL FOR INOPERABLE COLORECTAL CANCER LIVER METASTASES, A SINGLE CENTER EXPERIENCE [J].
van Bael, K. ;
De Greve, J. ;
Delvaux, G. ;
Neyns, B. .
ANNALS OF ONCOLOGY, 2010, 21 :221-221
[28]   Preclinical and clinical study results of the combination of paclitaxel and 5-fluorouracil/folinic acid in the treatment of metastatic breast cancer [J].
Klaassen, U ;
Harstrick, A ;
Wilke, H ;
Seeber, S .
SEMINARS IN ONCOLOGY, 1996, 23 (01) :44-47
[29]   Oxaliplatin combined to 5-fluorouracil and folinic acid: an effective therapy in patients with advanced colorectal cancer [J].
Gerard, B ;
Bleiberg, H ;
Van Daele, D ;
Gil, T ;
Hendlisz, A ;
Di Leo, A ;
Fernez, B ;
Brienza, S .
ANTI-CANCER DRUGS, 1998, 9 (04) :301-305
[30]   5-fluorouracil (5-FU),folinic acid (FA) and oxaliplatin (FUFOX) as second chemotherapy in patients with metastatic colorectal cancer (MCRC) [J].
Andric, Z. ;
Murtezani, Z. ;
Kovcin, V ;
Gutovic, J. ;
Kostic, S. .
ANNALS OF ONCOLOGY, 2006, 17 :66-67
12345